You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Large cell lung cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
  • +5 more
  • Duarte, California
  • +1 more
Dec 7, 2022

Local Advanced NSCLC Trial (Toripalimab, Radical thoracic radiotherapy)

Not yet recruiting
  • Local Advanced Non-small Cell Lung Cancer
  • (no location specified)
Jun 2, 2023

Small Cell Lung Cancer Extensive Stage, Large Cell Neuroendocrine Carcinoma of the Lung Trial (LB2102)

Not yet recruiting
  • Small Cell Lung Cancer Extensive Stage
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • LB2102
  • (no location specified)
Jan 10, 2023

Sputum DNA Testing for Lung Cancer in China

Recruiting
  • Lung Cancer
  • +15 more
  • Diagnostic Test: Sputum DNA methylation analysis
  • chest CT or pathological examination
  • Guangzhou, Guangdong, China
    Nanfang Hospital of Southern Medccal University
Dec 29, 2022

Non Small Cell Lung Cancer Trial in Changsha (radiotherapy, Chemotherapy + immunotherapy)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • radiotherapy
  • Chemotherapy + immunotherapy
  • Changsha, Hunan, China
    Hunan Cancer Hospital
Oct 17, 2022

Small Cell Lung Cancer (SCLC), Large Cell Neuroendocrine Cancer (LCNEC), Neuroendocrine Prostate Cancer (NEPC) Trial (PT217)

Not yet recruiting
  • Small Cell Lung Cancer (SCLC)
  • +3 more
  • (no location specified)
Dec 7, 2022

Adenocarcinoma of the Lung, Adenosquamous Cell Lung Cancer, Large Cell Lung Cancer Trial in Los Angeles (radiation, other, drug)

Active, not recruiting
  • Adenocarcinoma of the Lung
  • +8 more
  • hypofractionated radiation therapy
  • +5 more
  • Los Angeles, California
    Jonsson Comprehensive Cancer Center
Dec 2, 2021

Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, Follicular Lymphoma Trial in Australia, China (BGB-10188,

Recruiting
  • Chronic Lymphocytic Leukemia
  • +9 more
  • Adelaide, Australia
  • +12 more
Jan 6, 2023

Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Triple Negative Breast Cancer Trial in United States

Recruiting
  • Non Small Cell Lung Cancer
  • +11 more
  • Denver, Colorado
  • +3 more
Jan 10, 2023

Lung Atypical Carcinoid Tumor, Lung Neuroendocrine Tumor, Lung Non-Small Cell Squamous Carcinoma Trial in Conroe, Houston

Recruiting
  • Lung Atypical Carcinoid Tumor
  • +13 more
  • Nivolumab
  • Stereotactic Body Radiation Therapy
  • Conroe, Texas
  • +2 more
Feb 25, 2022

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Germany (Atezolizumab)

Recruiting
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Berlin, Germany
  • +13 more
Jul 20, 2022

Non Small Cell Lung Cancer, Non Small Cell Lung Cancer Stage IIIB, NSCLC Stage IV Trial in Australia, United States (IMU-201

Recruiting
  • Non Small Cell Lung Cancer
  • +5 more
  • IMU-201 (administered as PD1-Vaxx)
  • Phoenix, Arizona
  • +5 more
Jan 19, 2022

Lung Tumors, Squamous Cell Lung Cancer, Adenocarcinoma of the Lung Trial in Guangzhou (Icotinib)

Recruiting
  • Lung Neoplasms
  • +6 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Jul 29, 2021

Melanoma, Non-small Cell Lung Carcinoma (NSCLC), Renal Cell Carcinoma (RCC) Trial in Gainesville, Jacksonville (LITT +

Recruiting
  • Melanoma
  • +14 more
  • LITT + Pembrolizumab
  • Gainesville, Florida
  • +1 more
Aug 22, 2022

Small Cell Lung Cancer, Uveal Melanoma, Ovarian Clear Cell Carcinoma Trial in United States (PLX2853)

Completed
  • Small Cell Lung Cancer
  • +7 more
  • Scottsdale, Arizona
  • +4 more
Jul 20, 2022

NSCLC (NSCLC) Trial in Canada, Japan, United States (iSABR, 25 Gray in 1 fraction for small peripheral tumors, iSABR, 50 Gray in

Completed
  • Non-small Cell Lung Cancer (NSCLC)
  • iSABR, 25 Gray in 1 fraction for small peripheral tumors
  • +5 more
  • Stanford, California
  • +3 more
Jul 27, 2022

Solid Tumor, Adult, Head Neck Cancer, Non Small Cell Lung Cancer Trial in Worldwide (CX-2029)

Active, not recruiting
  • Solid Tumor, Adult
  • +4 more
  • Birmingham, Alabama
  • +24 more
Aug 5, 2022

Large Cell Neuroendocrine Carcinoma of the Lung Trial in Athens (Atezolizumab, Carboplatin, Etoposide)

Completed
  • Large Cell Neuroendocrine Carcinoma of the Lung
  • Athens, Greece
  • +1 more
Sep 16, 2023

SBRT, NSCLC, Non-metastatic Trial in United States (GC4711, Placebo)

Recruiting
  • SBRT
  • +2 more
  • Gilbert, Arizona
  • +11 more
Aug 9, 2022

Melanoma, NSCLC, Breast Cancer Trial in United States (CDX-1140, CDX-301, Pembrolizumab)

Completed
  • Melanoma
  • +25 more
  • Scottsdale, Arizona
  • +10 more
Sep 27, 2022

NSCLC Stage III Trial in Paris, Milan, Barcelona (durvalumab plus platinum-based chemo (cisplatin or carboplatin plus

Recruiting
  • Non-small Cell Lung Cancer Stage III
  • durvalumab plus platinum-based chemotherapy (cisplatin or carboplatin plus vinorelbine or pemetrexed)
  • +2 more
  • Paris, France
  • +2 more
May 30, 2022

Neuroendocrine Tumors, Carcinoma, Small Cell Lung, Neuroendocrine Carcinoma Trial in United Kingdom, United States (PEN-221)

Completed
Has Results
  • Neuroendocrine Tumors
  • +2 more
  • Fort Myers, Florida
  • +12 more
Nov 16, 2021

Ovarian Cancer, Epithelial, Gastric Cancer, GastroEsophageal Junction (GEJ) Cancer Trial in United Kingdom (NX-1607)

Recruiting
  • Ovarian Cancer, Epithelial
  • +14 more
  • Sutton, Surrey, United Kingdom
  • +6 more
Jul 22, 2022

Patients With Neuroendocrine Cancer of the Cervix

Recruiting
  • Cervical Large Cell Neuroendocrine Carcinoma
  • +21 more
  • Follow-Up
  • Medical Chart Review
  • Houston, Texas
    M D Anderson Cancer Center
Dec 5, 2022

Large-Cell Neuroendocrine Carcinoma Trial in Lexington (Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma,

Recruiting
  • Large-Cell Neuroendocrine Carcinoma
  • Treatment Specific for Non-Small Cell Carcinoma/Adenocarcinoma
  • Treatment for Small Cell Lung Cancer
  • Lexington, Kentucky
    Markey Cancer Center, University of Kentucky
Jan 12, 2022